Emerging treatments for HER2-positive early-stage breast cancer: focus on neratinib

Kourie HR, El Rassy E, Clatot F, de Azambuja E, Lambertini M

OncoTargets and Therapy 2017, 10:3363-3372

Published Date: 10 July 2017